<SEC-DOCUMENT>0001193125-21-139833.txt : 20210601
<SEC-HEADER>0001193125-21-139833.hdr.sgml : 20210601
<ACCEPTANCE-DATETIME>20210429141959
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-21-139833
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20210429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CATALYST BIOSCIENCES, INC.
		CENTRAL INDEX KEY:			0001124105
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				562020050
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		611 GATEWAY BLVD., SUITE 710
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-871-0761

	MAIL ADDRESS:	
		STREET 1:		611 GATEWAY BLVD., SUITE 710
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TARGACEPT INC
		DATE OF NAME CHANGE:	20000919
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g174614dsp01.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">


<IMG SRC="g174614dsp01a.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;29, 2021 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>VIA
EDGAR </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F Street, N.E. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Jason Drory, Office of Life
Sciences </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Re:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Catalyst Biosciences, Inc.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Filed March&nbsp;4, 2021</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>File <FONT
STYLE="white-space:nowrap">No.&nbsp;333-253874</FONT></B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>REQUEST FOR ACCELERATION OF EFFECTIVENESS</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Acceleration Request </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="78%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Requested&nbsp;Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">May&nbsp;3, 2021</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Requested&nbsp;Time:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4:00 p.m. Eastern Time</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Catalyst Biosciences, Inc. (the
&#147;<B><I>Company</I></B>&#148;) hereby requests that the Securities and Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;) take appropriate action to declare the Company&#146;s Registration Statement on Form S<B>-3</B> (File <FONT
STYLE="white-space:nowrap">No.&nbsp;333-253874)</FONT> effective at the &#147;Requested Date&#148; and &#147;Requested Time&#148; set forth above or as soon thereafter as practicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company hereby authorizes Stephen Thau, who is an attorney with the Company&#146;s outside legal counsel, Orrick, Herrington&nbsp;&amp;
Sutcliffe LLP, to orally modify or withdraw this request for acceleration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company requests that it be notified of such effectiveness
by a telephone call to Mr.&nbsp;Thau at (212) <FONT STYLE="white-space:nowrap">506-5076.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature page follows] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CATALYST BIOSCIENCES, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">/s/ Clinton Musil</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Clinton Musil</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Financial Officer</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Nassim Usman, Ph.D., Catalyst Biosciences, Inc. </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Stephen Thau, Esq., Orrick, Herrington&nbsp;&amp; Sutcliffe LLP </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g174614dsp01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g174614dsp01.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M\CBBF W1^7D!AW')/-=>#QKKR<9Z,G'Y<L-%3IMM=3JJ](\<* "@ H * "@
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M#PV\]K,\,HE0!D.#@GF@#HJ ,.RO6L_$MWI%Q.\AG7[7;ESG"GAD_ C(]C0
MOBBZNX-,CM[!BEY>3+;Q.#]PGDM^ !H HWDVHW>JQ>';*[>%8+=9+J]ZR'L
M/0GKF@!S>'=7L_W]AXBNY9D^8179#QR?[)[@'U% &CJ6E7>HB!EU6XL71<.M
ML?E8_C0!SPTK4CXF;2O^$CU#RQ:"XW[AG)<KCZ<4P.DTG2KC36E,VJ75Z'
M$Y!VX],4@-.@"EJ=T;6VPAQ(YP/;WKCQE=TJ>F[.C#T^>6NR.<KYX]8W=)LO
M*C\^0?.WW0>PKV\#A^1>TENSS<35YGR+8=KVG?VKHMS:+CS&7*9_O#D5U8FE
M[6DX$X2O["M&;V/&V4HQ5A@@X(/:OE-M#[A.^J/2_ >HBYT4V9&'M6QUZJQ)
M']17T.6U>:ER=CY7-Z')6]ITE^AU5>D>.% !0!R7Q .-,TS'_01B_DU '6T
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M_H5 '01W]I)?2V*7"&ZB 9X@?F4'H<?YZT +??9183F]5#:JA:4.,C:!DY%
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MX1M[G3HYK^]O9[V9 YG^T,"A(S\H'&/J#2 N[;OP[X8O9)[][Z2WC=XGE7D
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M$$GG&: )-;1=6U3PY#*+B&&Z\UGCW-&XQ'N ..00: +?_"&Z3ZW?_@5)_C0
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J 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g174614dsp01a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g174614dsp01a.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MDXX.<CGG- %AEL;>.X9/*@,?,CHJ@H<=>G7!_6@ M$LY((DA0,+7$:ATPT9
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C !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
